---
title: "AstraZeneca Profit, Revenue Lifted by Cancer Drugs"
date: 2025-07-29T20:00:14+08:00
categories: ["finance"]
tags: ["LSE:AZN"]
summary: "AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US. Chief Executive Officer Pascal Soriot has "
source_url: "https://www.bloomberg.com/news/videos/2025-07-29/astrazeneca-profit-revenue-lifted-by-cancer-drugs-video"
---

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US. Chief Executive Officer Pascal Soriot has turned the company into an oncology powerhouse, and increasing the company’s presence in the U.S.. The company pledged $50 billion by 2030 in both production and research and development. Soriot told Bloomberg Businessweek Daily the company wants to work with states that work quickly and understand the pharmaceutical giant’s vision. (Source: Bloomberg)

---

*来源: [原文链接](https://www.bloomberg.com/news/videos/2025-07-29/astrazeneca-profit-revenue-lifted-by-cancer-drugs-video)*
